NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model

Neuroreport. 2001 Jul 20;12(10):2079-84. doi: 10.1097/00001756-200107200-00008.

Abstract

Pro-inflammatory cytokines have been shown to be involved in the genesis, persistence, and severity of neuropathic pain following nerve injury. The transcription factor, nuclear factor-kappa B (NF-kappaB), plays a pivotal role in regulating pro-inflammatory cytokine gene expression. To elucidate the role of NF-kappaB in the pathogenesis of neuropathic pain, using a gene-based approach of NF-kappaB decoy, we tested whether the activated NF-kappaB affected pain behavior via the expression of inflammatory mediators. Single endoneurial injections of NF-kappaB decoy, at the site of nerve lesion, significantly alleviated thermal hyperalgesia for up to 2 weeks and suppressed the expression of mRNA of the inflammatory cytokines, iNOS, and adhesion molecules at the site of nerve injury. This finding suggests that a perineural inflammatory cascade, that involves NF-kappaB, is involved in the pathogenesis of neuropathic pain.

MeSH terms

  • Animals
  • Cell Adhesion Molecules
  • Cytokines / metabolism*
  • Disease Models, Animal
  • Hot Temperature
  • Hyperalgesia / drug therapy
  • Hyperalgesia / metabolism*
  • Male
  • NF-kappa B / metabolism
  • NF-kappa B / pharmacology*
  • NF-kappa B / therapeutic use
  • Neuralgia / drug therapy
  • Neuralgia / metabolism*
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type II
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Spinal Nerves / drug effects
  • Spinal Nerves / metabolism

Substances

  • Cell Adhesion Molecules
  • Cytokines
  • NF-kappa B
  • RNA, Messenger
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat